Tectonic Therapeutic | AVRO - Equity Capital And Reserves

Stock Price
24.00
Daily Change
0.78 3.36%
Monthly
16.62%
Yearly
-43.66%
Q1 Forecast
19.37

Tectonic Therapeutic reported $267.53M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alnylam Pharmaceuticals USD 233.89M 16.7M Sep/2025
Celltrion KRW 16.7T 182.36B Sep/2025
Cspc Pharmaceutical CNY 33.25B 984.93M Jun/2025
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
MacroGenics USD 67M 20.38M Sep/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 55.1M 229K Jun/2025
Neuren Pharmaceuticals AUD 323.27M 40.63M Jun/2025
Organigram Holdings CAD 349.13M 36.37M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Pharma Mar EUR 197.51M 4.02M Sep/2025
Qiagen NV USD 3.65B 143.93M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Sarepta Therapeutics USD 1.32B 37.26M Sep/2025
Sartorius EUR 2.67B 9.9M Sep/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Takeda JPY 7.64T 513.39B Dec/2025
Tilray USD 1.51B 1.22B Mar/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025